NGR-hTNF and doxorubicin in relapsed small-cell lung cancer (SCLC)

被引：0
|
作者：
Cavina, Raffaele
Gregorc, Vanesa
Novello, Silvia
Grossi, Francesco
Santoro, Armando
Vigano, Maria Grazia
Levra, Matteo G.
Lambiase, Antonio
Bordignon, Claudio
机构：
[1] Humanitas Canc Ctr, Rozzano, Italy
[2] Ist Sci San Raffaele, Dept Oncol, Milan, Italy
[3] Univ Turin, Thorac Oncol Unit, AUO San Luigi, Orbassano, Italy
[4] Natl Canc Res Ctr, Lung Canc Unit, Genoa, Italy
[5] Humanitas Canc Ctr, Dept Oncol, Rozzano, Italy
[6] MolMed, Milan, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7085
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Mechanism of Action of the Tumor Vessel Targeting Agent NGR-hTNF: Role of Both NGR Peptide and hTNF in Cell Binding and Signaling
    Valentinis, Barbara
    Porcellini, Simona
    Asperti, Claudia
    Cota, Manuela
    Zhou, Dan
    Di Matteo, Paola
    Garau, Gianpiero
    Zucchelli, Chiara
    Avanzi, Nilla Roberta
    Rizzardi, Gian Paolo
    Degano, Massimo
    Musco, Giovanna
    Traversari, Catia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (18)
  • [22] Phase II trial of vinorelbine plus doxorubicin in relapsed small-cell lung cancer
    Johnson, E
    Lake, D
    Herndon, JE
    Box, JW
    Lynch, TJ
    Green, MR
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (01): : 19 - 23
  • [23] A phase IIa study of ABT-263 in patients with relapsed small-cell lung cancer (SCLC)
    Rudin, C. M.
    Oliveira, M. R.
    Garon, E. B.
    Bonomi, P.
    Camidge, D. R.
    Nolan, C.
    Busman, T.
    Krivoshik, A.
    Humerickhouse, R.
    Gandhi, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [24] HEXAMETHYLMELAMINE (ALTRETAMINE) IN SMALL-CELL LUNG-CANCER (SCLC)
    COMIS, RL
    CANCER TREATMENT REVIEWS, 1991, 18 : 85 - 90
  • [25] Small-cell lung cancer (SCLC): is angiogenesis a relevant target?
    Loriot, Yohann
    Abedallaa, Nader
    Baey, Charlotte
    Tremblay, Lise
    Besse, Benjamin
    Planchard, David
    Guigay, Joel
    Soria, Jean C.
    De Montpreville, Vincent T.
    Brambilla, Elisabeth
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S808 - S808
  • [26] Advances in Small-Cell Lung Cancer (SCLC) Translational Research
    Drapkin, Benjamin J.
    Rudin, Charles M.
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2021, 11 (04):
  • [27] Randomized Phase II Trial of NGR-hTNF and Chemotherapy in Chemo-naive Patients With Non-small Cell Lung Cancer (NSCLC) - Preliminary Results
    Gregorc, V.
    Zilembo, N.
    Grossi, F.
    Rossoni, G.
    Pietrantonio, F.
    Rijavec, E.
    Citterio, G.
    Platania, M.
    Lambiase, A.
    Bordignon, C.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S596 - S596
  • [28] Combination chemotherapy for relapsed small-cell lung cancer
    Kalemkerian, Gregory P.
    LANCET ONCOLOGY, 2016, 17 (08): : 1033 - 1035
  • [29] Gefitinib efficacy in relapsed small-cell lung cancer
    Dincer, Murat
    Aksoy, Sercan
    Kilickap, Saadettin
    Altundag, Kadri
    LUNG CANCER, 2006, 53 (02) : 255 - 255
  • [30] Managing Patients With Relapsed Small-Cell Lung Cancer
    Gong, Jun
    Salgia, Ravi
    JOURNAL OF ONCOLOGY PRACTICE, 2018, 14 (06) : 359 - +
12345